Introduction：Basic information about CALCIUM GLYCEROPHOSPHATE CAS 27214-00-2, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
CALCIUM GLYCEROPHOSPHATE Basic information
| Product Name: | CALCIUM GLYCEROPHOSPHATE |
| Synonyms: | Calcium glycerinophosphate;CALCIUMGLYCEROPHOSPHATE,FCC;neurosin;CALCIUM GLYCEROPHOSPHATE POWDER;Glycerol phosphate calcium salt;calcium (2-hydroxy-1-methylol-ethyl) phosphate;calcium 1,3-dihydroxypropan-2-yl phosphate;Calcium Glycerophosphoric |
| CAS: | 27214-00-2 |
| MF: | C3H7CaO6P |
| MW: | 210.14 |
| EINECS: | 248-328-5 |
| Product Categories: | Ca (Calcium) Compounds;Classes of Metal Compounds;Typical Metal Compounds;27214-00-2 |
| Mol File: | 27214-00-2.mol |
|
CALCIUM GLYCEROPHOSPHATE Chemical Properties
| Melting point | > 170℃ |
| density | 1.82-1.855[at 20℃] |
| vapor pressure | 0Pa at 25℃ |
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | Sparingly soluble in water, practically insoluble in ethanol (96 per cent). |
| form | powder to crystal |
| color | White to Almost white |
| Water Solubility | faint turbidity |
| Merck | 14,1670 |
| Cosmetics Ingredients Functions | ANTIPLAQUE
ORAL CARE |
| InChI | InChI=1S/C3H9O6P.Ca/c4-1-3(5)2-9-10(6,7)8;/h3-5H,1-2H2,(H2,6,7,8);/q;+2/p-2 |
| InChIKey | IWIRHXNCFWGFJE-UHFFFAOYSA-L |
| SMILES | P([O-])([O-])(=O)OCC(O)CO.[Ca+2] |
| LogP | -2.31 at 20℃ |
| CAS DataBase Reference | 27214-00-2(CAS DataBase Reference) |
| EPA Substance Registry System | 1,2,3-Propanetriol, mono(dihydrogen phosphate), calcium salt (1:1) (27214-00-2) |
Safety Information
| Safety Statements | 22-24/25 |
| TSCA | TSCA listed |
| HS Code | 2919.90.5050 |
CALCIUM GLYCEROPHOSPHATE Usage And Synthesis
| Chemical Properties | White or almost white powder, hygroscopic. |
| Uses | Calcium glycerylphosphate (or calcium glycerophosphate) is a mineral supplement. |
| Flammability and Explosibility | Not classified |
| in vivo | Monocalcium glycerophosphate (at a concentration that meets the needs for intravenous injection in piglets of 15 mmol Ca and 15 mmol P/kg/day, via jugular catheterization, seven days) can serve as an effective source of calcium and phosphorus in piglet TPN solutions, preventing the development of bone mineralization from intravenous nutrition[3]. | Animal Model: | Piglets[3] | | Dosage: | The concentration meets the requirement of 15 mmol of Ca and 15 mmol of P per kg per day for intravenous injection in piglets; 7 days | | Administration: | Jugular vein catheterization | | Result: | Increased the retention of calcium and phosphorus, the mineralization of the little pigs' bones had noticeably improved, with higher calcium to lean dry weight ratios observed in the humerus and femur. |
|
CALCIUM GLYCEROPHOSPHATE Preparation Products And Raw materials
| Raw materials | Calcium hydroxide-->PHOSPHOGLYCOLIC ACID |
